全文获取类型
收费全文 | 121675篇 |
免费 | 8878篇 |
国内免费 | 3173篇 |
专业分类
耳鼻咽喉 | 1438篇 |
儿科学 | 3412篇 |
妇产科学 | 4090篇 |
基础医学 | 13800篇 |
口腔科学 | 2209篇 |
临床医学 | 9629篇 |
内科学 | 17628篇 |
皮肤病学 | 1834篇 |
神经病学 | 18502篇 |
特种医学 | 3124篇 |
外国民族医学 | 17篇 |
外科学 | 9819篇 |
综合类 | 12606篇 |
现状与发展 | 6篇 |
一般理论 | 12篇 |
预防医学 | 9006篇 |
眼科学 | 2950篇 |
药学 | 11793篇 |
91篇 | |
中国医学 | 6874篇 |
肿瘤学 | 4886篇 |
出版年
2023年 | 2057篇 |
2022年 | 2796篇 |
2021年 | 5530篇 |
2020年 | 5055篇 |
2019年 | 6125篇 |
2018年 | 5726篇 |
2017年 | 4891篇 |
2016年 | 4108篇 |
2015年 | 3979篇 |
2014年 | 8059篇 |
2013年 | 10399篇 |
2012年 | 7226篇 |
2011年 | 7434篇 |
2010年 | 5840篇 |
2009年 | 5296篇 |
2008年 | 5074篇 |
2007年 | 4592篇 |
2006年 | 3983篇 |
2005年 | 3441篇 |
2004年 | 3171篇 |
2003年 | 2905篇 |
2002年 | 2222篇 |
2001年 | 2011篇 |
2000年 | 1752篇 |
1999年 | 1582篇 |
1998年 | 1364篇 |
1997年 | 1392篇 |
1996年 | 893篇 |
1995年 | 1054篇 |
1994年 | 928篇 |
1993年 | 788篇 |
1992年 | 680篇 |
1991年 | 628篇 |
1990年 | 620篇 |
1989年 | 527篇 |
1988年 | 401篇 |
1987年 | 344篇 |
1986年 | 386篇 |
1985年 | 1041篇 |
1984年 | 1285篇 |
1983年 | 706篇 |
1982年 | 875篇 |
1981年 | 732篇 |
1980年 | 677篇 |
1979年 | 585篇 |
1978年 | 476篇 |
1977年 | 397篇 |
1976年 | 390篇 |
1975年 | 361篇 |
1973年 | 272篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
51.
����һ���� Ȫ 《中国实用外科杂志》2019,39(3):223-225
妊娠期甲状腺癌的诊治是目前甲状腺疾病诊治的热点和难点问题之一。妊娠期发现甲状腺癌对临床医生和孕妇都是一个极大的挑战,应通过多学科协作,尽快明确诊断,全面、合理的评估孕妇和胎儿的情况,选择最合适的治疗和随诊方式,避免对孕妇和胎儿产生副反应,维持正常孕期,获得最佳的治疗效果。 相似文献
52.
目的:系统评价丹红注射液对急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)围手术期心功能和心肌梗塞溶栓治疗(TIMI)血流分级的影响。方法:计算机检索CNKI,万方数据库,维普数据库,Pub Med,CBM,Web of Science,The Cochrane Library共7个数据库,全面采集在PCI围手术期应用丹红注射液治疗急性心梗的临床试验,采用Cochrane风险评价表进行文献质量评价,运用Revman 5.3软件进行Meta分析。结果:共纳入12个临床试验,包含1131例患者,其中丹红治疗组569例,对照组562例,结果显示在常规治疗的基础上加入丹红注射液治疗,患者的左室射血分数明显增高[均数差(MD)=6.62,95%可信区间(CI)(4.91,8.34),P<0.00001],TIMI分级3级患者明显增多[相对危险度(RR)=0.22,95%CI(0.12,0.41),P<0.00001],脑利钠肽水平明显降低[MD=-151.86,95%CI(-247.00,-56.72),P=0.002]。结论:丹红注射液可以提高急性心梗PCI围手术期心功能和增加TIMI血流的分级。 相似文献
53.
54.
55.
Harit Kapoor Kush Raj Lohani Tommy H. Lee Devendra K. Agrawal Sumeet K. Mittal 《CTS Clinical and Translational Science》2015,8(6):841-847
Esophageal adenocarcinoma is the fastest rising cancer in the United States. It develops from long‐standing gastroesophageal reflux disease which affects >20% of the general population. It carries a very poor prognosis with 5‐year survival <20%. The disease is known to sequentially progress from reflux esophagitis to a metaplastic precursor, Barrett''s esophagus and then onto dysplasia and esophageal adenocarcinoma. However, only few patients with reflux develop Barrett''s esophagus and only a minority of these turn malignant. The reason for this heterogeneity in clinical progression is unknown. To improve patient management, molecular changes which facilitate disease progression must be identified. Animal models can provide a comprehensive functional and anatomic platform for such a study. Rats and mice have been the most widely studied but disease homology with humans has been questioned. No animal model naturally simulates the inflammation to adenocarcinoma progression as in humans, with all models requiring surgical bypass or destruction of existing antireflux mechanisms. Valuable properties of individual models could be utilized to holistically evaluate disease progression. In this review paper, we critically examined the current animal models of Barrett''s esophagus, their differences and homologies with human disease and how they have shaped our current understanding of Barrett''s carcinogenesis. 相似文献
56.
57.
《Drug metabolism and pharmacokinetics》2020,35(1):56-70
Hepatic uptake mediated by organic anion transporting polypeptide (OATP) 1B1 and 1B3 can serve as a major elimination pathway for various anionic drugs and as a site of drug-drug interactions (DDIs). This article provides an overview of the in vitro approaches used to predict human hepatic clearance (CLh) and the risk of DDIs involving OATP1Bs. On the basis of the so-called extended clearance concept, in vitro–in vivo extrapolation methods using human hepatocytes as in vitro systems have been used to predict the CLh involving OATP1B-mediated hepatic uptake. CLh can be quantitatively predicted using human donor lots possessing adequate OATP1B activities. The contribution of OATP1Bs to hepatic uptake can be estimated by the relative activity factor, the relative expression factor, or selective inhibitor approaches, which offer generally consistent outcomes. In OATP1B1 inhibition assays, substantial substrate dependency was observed. The time-dependent inhibition of OATP1B1 was also noted and may be a mechanism underlying the in vitro–in vivo differences in the inhibition constant of cyclosporine A. Although it is still challenging to quantitatively predict CLh and DDIs involving OATP1Bs from only preclinical data, understanding the utility and limitation of the current in vitro methods will pave the way for better prediction. 相似文献
58.
59.
60.
Autoimmune thyroid diseases (AITD) and Type 1 diabetes (T1D) frequently occur in the same individual pointing to a strong shared genetic susceptibility. Indeed, the co-occurrence of T1D and AITD in the same individual is classified as a variant of the autoimmune polyglandular syndrome type 3 (designated APS3v). Our aim was to identify new genes and mechanisms causing the co-occurrence of T1D + AITD (APS3v) in the same individual using a genome-wide approach. For our discovery set we analyzed 346 Caucasian APS3v patients and 727 gender and ethnicity matched healthy controls. Genotyping was performed using the Illumina Human660W-Quad.v1. The replication set included 185 APS3v patients and 340 controls. Association analyses were performed using the PLINK program, and pathway analyses were performed using the MAGENTA software. We identified multiple signals within the HLA region and conditioning studies suggested that a few of them contributed independently to the strong association of the HLA locus with APS3v. Outside the HLA region, variants in GPR103, a gene not suggested by previous studies of APS3v, T1D, or AITD, showed genome-wide significance (p < 5 × 10−8). In addition, a locus on 1p13 containing the PTPN22 gene showed genome-wide significant associations. Pathway analysis demonstrated that cell cycle, B-cell development, CD40, and CTLA-4 signaling were the major pathways contributing to the pathogenesis of APS3v. These findings suggest that complex mechanisms involving T-cell and B-cell pathways are involved in the strong genetic association between AITD and T1D. 相似文献